Shijiazhuang Kaida Bioengineering

Shijiazhuang Kaida Bioengineering Co., Ltd. is a China-based pharmaceutical and medical device manufacturer specializing in large and small volume injections, medical devices, and in vitro diagnostic (IVD) reagents. Originally established in 1991 as a school-run enterprise affiliated with Hebei Medical University, the company underwent a formal corporate restructuring in 2022. Its commercial portfolio features more than 30 approved injection products, including small molecule therapeutics and animal-derived peptide or protein extracts targeting cerebrovascular diseases, oncology, and respiratory conditions. Additionally, the company develops and manufactures IVD products such as monoclonal antibody-based blood grouping reagents and ELISA diagnostic kits for infectious diseases. Headquartered in Shijiazhuang, Hebei Province, the company operates integrated R&D, manufacturing, and sales platforms with a workforce of over 300 employees.